Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Year of publication: |
August 2019
|
---|---|
Authors: | Conti, Rena M. |
Other Persons: | Berndt, Ernst R. (contributor) |
Institutions: | National Bureau of Economic Research (contributor) |
Publisher: |
2019: Cambridge, Mass : National Bureau of Economic Research |
Subject: | USA | United States | Generika | Generic drugs | Arzneimittelmarkt | Pharmaceutical market | Arzneimittel | Pharmaceuticals | Wettbewerb | Competition |
Extent: | 1 Online-Ressource illustrations (black and white) |
---|---|
Series: | NBER working paper series ; no. w26194 |
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | System requirements: Adobe [Acrobat] Reader required for PDF files Mode of access: World Wide Web Hardcopy version available to institutional subscribers |
Other identifiers: | 10.3386/w26194 [DOI] |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Essays on the economics of pharmaceuticals
Virabhak, Suchin, (2005)
-
The new prescription drug paradox : pipeline pressure and rising prices
Ellyson, Alice M., (2018)
-
Four Facts Concerning Competition in U.S. Generic Prescription Drug Markets
Conti, Rena, (2019)
- More ...
-
The Surprising Hybrid Pedigree of Measures of Diversity and Economic Concentration
Adajar, Paolo M., (2019)
-
The Geography of Prescription Pharmaceuticals Supplied to the U.S : Levels, Trends and Implications
Kaygisiz, Neriman Beste, (2019)
-
Early Retirement and Public Disability Insurance Applications : Exploring the Impact of Depression
Conti, Rena M., (2006)
- More ...